Carlo Rosa - DiaSorin SpA CEO, General Manager and Executive Director
| DSRLF Stock | USD 106.85 0.32 0.30% |
CEO
Mr. Carlo Rosa has acted as Chief Executive Officer, Executive Director, General Manager of Diasorin S.p.A. since 2006. He graduated in Chemistry from Universita degli Studi di Torino. From 1990 to 1998, he was responsible for various research projects at Biomedica SpA and INCSTAR Inc. In 1998, he served as Director of Marketing and Sales at DiaSorin. In 2000, he was appointed General Manager of DiaSorin Group. In 2002, he was appointed Chief Executive Officer at DiaSorin GmbH. Currently, he serves as Sole Director at Sarago Srl and as Director of TOP Srl and Diasorin Inc. since 2006.
| Age | 57 |
| Tenure | 18 years |
| Phone | 39 01 614871 |
| Web | https://diasoringroup.com |
DiaSorin SpA Management Efficiency
The company has return on total asset (ROA) of 0.0902 % which means that it generated a profit of $0.0902 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.198 %, meaning that it generated $0.198 on every $100 dollars invested by stockholders. DiaSorin SpA's management efficiency ratios could be used to measure how well DiaSorin SpA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | CEO Age | ||
| Udit Batra | Waters | 53 | |
| Rainer Blair | Danaher | 60 | |
| Prahlad Singh | Revvity | 59 | |
| Steven Chapman | Natera Inc | 45 | |
| Patrick Kaltenbach | Mettler Toledo International | 61 | |
| Oliver Filliol | Mettler Toledo International | 54 | |
| Thomas Joyce | Danaher | 58 | |
| Michael McMullen | Agilent Technologies | 63 | |
| Jonathan Mazelsky | IDEXX Laboratories | 63 | |
| JoAnn Reed | Waters | 64 | |
| Jacob Thaysen | Illumina | 49 | |
| James JD | Charles River Laboratories | 73 | |
| Emily Leproust | Twist Bioscience Corp | 51 | |
| Helmy Eltoukhy | Guardant Health | 45 | |
| Marc Casper | Thermo Fisher Scientific | 56 | |
Management Performance
| Return On Equity | 0.2 | |||
| Return On Asset | 0.0902 |
DiaSorin SpA Leadership Team
Elected by the shareholders, the DiaSorin SpA's board of directors comprises two types of representatives: DiaSorin SpA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DiaSorin. The board's role is to monitor DiaSorin SpA's management team and ensure that shareholders' interests are well served. DiaSorin SpA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DiaSorin SpA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fabrizio Bonelli, Chief Officer | ||
| Carlo Rosa, CEO, General Manager and Executive Director | ||
| Piergiorgio Pedron, Senior Corporate VP and CFO | ||
| Ulisse Spada, Mang Department | ||
| Angelo Rago, Pres Corp | ||
| Stefano Ronchi, Sr. Corporate VP of HR | ||
| Ugo Gay, Sr Operations | ||
| Chen Even, Chief Commercial Officer and Executive Director | ||
| Riccardo Fava, Director of Investor Relations and Corporate Communication |
DiaSorin Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is DiaSorin SpA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.0902 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.29 % | |||
| Current Valuation | 8.64 B | |||
| Shares Outstanding | 53.84 M | |||
| Shares Owned By Insiders | 57.50 % | |||
| Shares Owned By Institutions | 22.36 % | |||
| Price To Earning | 26.36 X | |||
| Price To Book | 4.73 X |
Currently Active Assets on Macroaxis
Other Information on Investing in DiaSorin Pink Sheet
DiaSorin SpA financial ratios help investors to determine whether DiaSorin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DiaSorin with respect to the benefits of owning DiaSorin SpA security.